
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.890 | 2.080 | 0.190 |
Shares | 98.110 | 98.110 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 18.117 | 17.702 |
Price to Book | 3.360 | 3.311 |
Price to Sales | 2.526 | 2.189 |
Price to Cash Flow | 14.983 | 13.890 |
Dividend Yield | 2.682 | 2.929 |
5 Years Earnings Growth | 10.819 | 11.893 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 32.070 | 30.871 |
Financial Services | 23.730 | 21.385 |
Consumer Defensive | 13.900 | 12.663 |
Industrials | 10.760 | 16.051 |
Basic Materials | 9.440 | 8.235 |
Consumer Cyclical | 7.490 | 5.375 |
Technology | 2.610 | 3.455 |
Number of long holdings: 34
Number of short holdings: 3
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Roche Holding Participation | CH0012032048 | 9.56 | 259.00 | -1.11% | |
Novartis | CH0012005267 | 9.11 | 90.10 | -1.72% | |
Nestle | CH0038863350 | 8.23 | 85.07 | -1.32% | |
UBS Group | CH0244767585 | 5.60 | 27.42 | +1.14% | |
Holcim | CH0012214059 | 5.43 | 97.12 | +1.29% | |
Richemont | CH0210483332 | 4.82 | 156.00 | +1.04% | |
Zurich Insurance Group | CH0011075394 | 4.65 | 569.80 | -1.21% | |
Swiss Re | CH0126881561 | 4.41 | 146.35 | -1.41% | |
ABB | CH0012221716 | 4.19 | 47.16 | +1.14% | |
Alcon | CH0432492467 | 3.99 | 79.20 | -1.07% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Kapital Plus P EUR | 7.6M | 0.91 | -2.17 | 2.49 | ||
DE000A2DU1Y2 | 16.86M | -0.15 | -3.20 | 1.46 | ||
Kapital Plus I EUR | 97.24M | 2.43 | 0.24 | 2.33 | ||
Kapital Plus P2 EUR | 1.83M | 2.45 | 0.39 | 2.48 | ||
Kapital Plus A EUR | 2.54B | -1.26 | -0.49 | 1.05 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review